ASX Share rice
Sun 09 May 2021 - 04:51:pm (Sydney)

CDX Share Price

CARDIEX LIMITEDCDXHealth Care Equipment & Services

CDX Company Information

Name:

CardieX Limited

Sector:

Healthcare

Industry:

Medical Devices

GIC Industry:

Health Care Equipment & Supplies

GIC Sub Industry:

Health Care Equipment

Address:

15 Lime Street Sydney NSW Australia 2000

Phone:

61 2 9874 8761

Exec. Chairman:

Mr. Niall Charles Edgar Cairns

CEO, MD & Exec. Director:

Mr. Craig R. Cooper

CFO, Joint Company Sec. & Director:

Mr. Jarrod Travers White C.A., B.Bus, CA, CTA

VP of Operations & Pres of ATCOR Medical:

Mr. Chris Dax

Global Head of Marketing & Communications:

Mr. Antony Sloan

VP of Corp. Devel.:

Mr. ZiHan Lin

Exec. VP & Head of Global Sales for AtCor Medical Division:

Mr. Douglas T. Kurschinski

Chief Medical Officer:

Dr. Steven Kesten

Chief Product Officer:

Dr. Mark Gorelick

Joint Company Sec.:

Mr. Philip Leighfield

Company Overview:

CardieX Limited designs, manufactures, and markets medical devices for use in cardiovascular health management in the Americas, Europe, and the Asia Pacific. The company develops, markets, and distributes medical technologies that measure patient risk for hypertension, cardiovascular disease (CVD), and other related vascular disorders. It also provides TeleHealth Services, which provides digital, e-commerce, and mobile tools for patients to connect online with health coaches. The company offers its devices and services to hospitals, clinics, research institutions and pharmaceutical companies. CardieX Limited has a strategic collaboration with Blumio Inc. to develop wearable sensor; and a joint development agreement with inHealth to develop hypertension and cardiovascular programs for the products. The company was formerly known as AtCor Medical Holdings Limited and changed its name to CardieX Limited in June 2018. CardieX Limited was founded in 1994 and is headquartered in Sydney, Australia.

CDX Share Price Information

Shares Issued:

0.92B

Market Capitalisation:

$62.86M

Revenue (TTM):

$5.53M

Revenue Per Share (TTM):

$0.01

Earnings per Share:

$-0.005

Profit Margin:

-0.6197

Operating Margin (TTM):

$-0.49

Return On Assets (TTM):

$-0.16

Return On Equity (TTM):

$-0.49

Quarterly Revenue Growth (YOY):

0.18

Gross Profit(TTM):

$4.40M

Diluted Earnings Per Share (TTM):

$-0.004

CDX CashFlow Statement

CashFlow Date:

2020-06-30

Investments:

$-3,699,113

Change To Liabilities:

$854.32K

Total Cashflow From Investing Activities:

$-3,699,113

Net Borrowings:

$1.53M

Net Income:

$-3,320,427

Total Cash From Operating Activities:

$-1,698,851

Depreciation:

$220.15K

Other Cashflow From Investing Activities:

$-3,490,217

Change To Inventory:

$-40,749

Change To Account Receivables:

$-15,951

Sale Purchase Of Stock:

$1M

Capital Expenditures:

$175.20K

CDX Income Statement

Income Date:

2020-06-30

Income Before Tax:

$-3,320,430

Net Income:

$-3,320,430

Gross Profit:

$3.92M

Operating Income:

$-3,189,570

Interest Expense:

$164.74K

Total Revenue:

$4.62M

Cost Of Revenue:

$698.18K

CDX Balance Sheet

Balance Sheet Date:

2020-06-30

Intangible Assets:

$56.19K

Total Liabilities:

$4.80M

Total Stockholder Equity:

$5.88M

Other Current Liabilities:

$1.70M

Total Assets:

$10.68M

Common Stock:

$53.13M

Other Current Assets:

$57.58K

Retained Earnings:

$-49,217,488

Other Assets:

$5.02M

Cash:

$2.06M

Total Current Liabilities:

$3.64M

Short-Term Debt:

$251.77K

Property - Plant & Equipment:

$565.64K

Net Tangible Assets:

$5.82M

Long-Term Investments:

$5.30M

Total Current Assets:

$4.69M

Long-Term Debt:

$0.96M

Net Receivables:

$2.20M

Short-Term Investments:

$5.98M

Inventory:

$259.68K

Accounts Payable:

$537.40K

Non Currrent Assets (Other):

$60.25K

Short-Term Investments:

$5.98

Non Current Liabilities Total:

$1.15M

CDX Share Price History

CDX News

21 Apr, 2021
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly...
21 Jan, 2021
Unless you borrow money to invest, the potential losses are limited. But if you pick the right stock, you can make a...
22 Nov, 2020
Craig Cooper has been the CEO of CardieX Limited (ASX:CDX) since 2017, and this article will examine the executive's...
24 Aug, 2020
We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are...
06 Jul, 2020
CardieX Limited (ASX: CDX, CardieX, the Company) 100% subsidiary ATCOR has submitted a US patent application in regards to its recently announced wearable sensor technology (ASX: 24/04/2020).
CardieX Limited (ASX: CDX) (CardieX, the Company) announces that its wearables co-development partner, Blumio, Inc, has entered into a significant partnership with global semiconductor company Infineon Technologies AG (Infineon) for the development and commercialization of sensor technology based on Infineons's radar chip and Blumio's software and algorithms.